This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-01 and is reviewed periodically as new material appears.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
== Research == Current research in regenerative medicine spans a continuous spectrum from fundamental cell biology to clinical translational engineering, focusing on deciphering and manipulating the signaling pathways that govern tissue morphogenesis, cellular differentiation, and scarless wound healing. Rather than merely managing chronic symptoms, active laboratory investigations aim to understand why adult mammalian tissues lose the regenerative capacities inherent in lower vertebrates and human embryonic states. Research strategies are broadly categorized into three interdependent vectors: cell-based therapies, which isolate and direct stem cell fates; biomaterial design, which engineers bioactive scaffolds to mimic the native extracellular matrix; and the delivery of localized biochemical cues, such as growth factors and gene-editing complexes, to orchestrate endogenous tissue repair. A major bottleneck in ongoing research is solving the scalability of functional vascularization, as complex engineered tissues cannot survive past the limits of oxygen diffusion without an integrated capillary network.
== Research == The first-in-human study, a phase 1 trial, was initiated in October 2017 and completed in September 2020 in postmenopausal women with breast cancer. The study investigated oral doses of vosilasarm of 50 mg/day to 150 mg/day, with the maximum tolerated dose found to be 100 mg/day. A phase 1/2 study proposal of vosilasarm for treatment of breast cancer was published in 2023. It will recruit up to 128 patients.
Wheatley is one of GLaDOS' Personality Cores, voiced by Stephen Merchant and introduced in Portal 2, where he has become autonomous from GLaDOS. He appears to help rescue Chell from the failing cryogenic storage facility, but inadvertently reactivates GLaDOS. Eventually, Wheatley guides Chell to initiate a core transfer, allowing him to take over GLaDOS' capabilities, turning him corrupt with power and sending Chell and the GLaDOS potato-battery module deep into the bowels of Aperture Science. GLaDOS reveals that Wheatley was designed by Aperture's scientists as "the dumbest moron that ever lived", designed to hamper her decision-making processes. Wheatley's incompetence threatens to destroy Aperture, and Chell and GLaDOS are forced to work together to stop him. At the end of the game, Wheatley is banished to space via a portal on the moon, with a corrupted core orbiting around him.
== Further reading == Insulin Basics for Diabetes American Diabetes Association (diabetes.org). Retrieved 2026-04-27. Insulin, Medicines, & Other Diabetes Treatments". National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Retrieved 2026-04-27.
Sources: en.wikipedia.org
On 2 August 2015, The FA Community Shield in England was broadcast in Ultra HD by broadcast company BT Sport, becoming the first live football game shown in Ultra HD on the world's first commercial Ultra HD channel. The match was shown on Europe's first Ultra HD channel, BT Sport Ultra HD where selected live English Premier League and European Champions League matches were broadcast. Fashion One 4K launched on 2 September 2015 becoming the first global Ultra HD TV channel. Reaching nearly 370 million households across the world, the fashion, lifestyle and entertainment network broadcasts via satellite from Measat at 91.5°E (for Asia Pacific, Middle East, Australia) and from SES satellites Astra 19.2°E (for Europe), SES-3 at 103°W (for North America), NSS-806 at 47.5°W (for South America). In September 2015, Eutelsat presented new consumer research, conducted by TNS and GfK, on Ultra HD and screen sales in key TV markets. The study looked at consumer exposure to Ultra HD, perceived benefits and willingness to invest in equipment and content. GfK predicts a 200% increase in Ultra HD screen sales from June to December 2015, with sales expected to reach five million by the end of the year. GfK also forecasts that Ultra HD screens in 2020 will represent more than 70% of total sales across Europe and almost 60% in the Middle East and North Africa. On 2 September 2015, Sony unveiled the Xperia Z5 Premium; the first smartphone with a 4K display. On 9 September 2015, Apple Inc. announced that their new smartphone the iPhone 6S could record video in 4K.
(2008) reported that the long hydrophobic Cys3-Cys4 loop is not required for rodlet assembly because its deletion does not affect the folding and physical properties of the monomeric protein, neither the morphology of the polymeric rodlet form. Instead, a region of the short Cys7-Cys8 loop, containing mainly uncharged polar residues, has been found to be critical for rodlet assembly. Characterization of EAS secondary elements involved in rodlet assembly have given insights into the mechanism behind class I hydrophobins self-assembly, but important structural differences with DewA, another class I hydrophobin, suggest that the mechanisms driving rodlet assembly vary among different types of hydrophobins. Like EAS, DewA also has a β-barrel core structure, but it differs significantly from it because of its considerable content of helical secondary elements. A unique feature of DewA is its capacity to exist as two types of conformers in solution, both able to form rodlet assemblies but at different rates. Despite these differences in structural and self-assembly mechanisms, both EAS and DewA form robust fibrillar monolayers, meaning that there must exist several pathways, protein sequences and tertiary conformations able to self-assemble into amphipathic monolayers. Further characterisation of both EAS and DewA and their rodlet self-assembly mechanisms will open up opportunities for rational design of hydrophobins with novel biotechnological applications.
A rotary valve (also called rotary-motion valve) is a type of valve in which the rotation of a passage or passages in a transverse plug regulates the flow of liquid, gas or dry bulk products through the attached pipes. The common stopcock is the simplest form of rotary valve. Rotary valves have been applied in numerous applications, including:
=== Complex carbon skeleton rearrangements === Another subset of radical SAM superfamily has been shown to catalyze carbon skeleton rearrangements especially in the areas of DNA repair and cofactor biosynthesis.
==== False information and fines ==== During the elections, Jornal da Band released false polling that showed Melo in the lead against d'Ávila. Melo's campaign would later post their findings onto his Instagram account. Jornal da Band would later correct the polling data and Melo's campaign removed the post from social media. He was later condemned by electoral courts under the Brazilian Election Justice and was made to pay 106,000 reais for spreading false information. The judge that made the decision made the call to forward the case to the Federal Police for a criminal investigation. Melo and Gomes were fined again through the Election Justice for 41,900 reais for a series of irregularities in the campaign's finances, including the use of provisions to print religiously styled pamphlets that displayed him appearing alongside city council candidates from the PTB, a party that had not formally become a member of his coalition. Allies of Melo also went around the city to spread rumors that if d'Ávila was elected, that she would close the city's churches and force people to eat dog meat.
Sources: en.wikipedia.org
=== Conventional lethal injection protocol === Typically, three drugs are used in lethal injection and are administered in the following order: midazolam for sedation, pancuronium bromide (Pavulon) is used to cause muscle paralysis and decreased neural transmission to the lungs, and potassium chloride to stop the heart.
==== France ==== France was one of the countries that inherited a knowledge of apple cultivation from both the Celtic Gauls and the later Romans, who ruled the country for approximately 500 years: both had knowledge of grafting and keeping apples. The earliest mentions of cider in this country go back to the Greek geographer Strabo: he speaks of the profusion of apple trees in Gaul and describes a cider-like drink. In the 9th century, Charlemagne, in the Capitulars, ordered skilled brewers (the Sicetores) to always be present on his estates to make him ale, "pommé" (pomacium), perry and all the liquors liable to be used as drinks, and also ordered an expansion of planting apple trees in what is now Northern France. French cidre (French pronunciation: [sidʁ]) is an alcoholic drink produced predominantly in Normandy and Brittany. It varies in strength from below 4% alcohol to considerably more. Cidre Doux is a sweet cider, usually up to 3% in strength. 'Demi-Sec' is 3–5% and Cidre Brut is a strong dry cider of 4.5% alcohol and above. Most French ciders are sparkling. Higher quality cider is sold in champagne-style bottles (cidre bouché). Many ciders are sold in corked bottles, but some screw-top bottles exist. In crêperies (crêpe restaurants) in Brittany, cider is generally served in traditional ceramic bowls (or wide cups) rather than glasses. A kir Breton (or kir normand) is a cocktail apéritif made with cider and cassis, rather than white wine and cassis for the traditional kir. The Domfrontais, in the Orne (Basse-Normandie), is famous for its pear cider (poiré).
"The Undeveloped Countries". The Humanist Outlook. London: Pemberton Publishing Co. ISBN 9780301667645. Boyd Orr, John; Beck, Robert Nelson (1970). Ethical Choice. London: Free Press. ISBN 978-0-02-902070-8 – via Internet Archive.
The Iranian foreign ministry said it was merely reviewing proposals from the US sent through mediators. On 25 March, Pakistani officials delivered a "15-point proposal" from the US to Iran, detailing a ceasefire plan. The US proposal included an end to Iran's nuclear program, limits on its missiles, reopening the Strait of Hormuz, restrictions on Iran's support for armed groups, and sanctions relief for Iran. The Iranians rejected the US proposal, with an anonymous official telling Press TV that "Iran will end the war when it decides to do so and when its own conditions are met". The Iranians issued a "5-point counter-proposal", including an end to US-Israeli attacks on Iran and pro-Iranian forces in Lebanon and Iraq, security guarantees to prevent future Israeli and US aggression, war reparations, and international recognition of Iranian sovereignty over the Strait of Hormuz. On 31 March, Pakistan and China delivered a "5 point initiative" for peace, calling for an immediate end to all hostilities and allowance of humanitarian aid into the region. Trump claimed on 1 April 2026 that Iran had just asked the US for a ceasefire and that the US would consider it once the Strait of Hormuz was "open, free, and clear. Until then, we are blasting Iran into oblivion ... back to the Stone Ages!". Iran's foreign ministry called the claim "false and baseless". The IRGC said the strait "will not be opened to the enemies of this nation through the ridiculous spectacle by the president of the US".
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.